StockData
Immix Biopharma, Inc. logo

Immix Biopharma, Inc. (IMMX) stock

IMMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$7.11−0.09 (-1.25%)

Close on Nov 18, 2026Market cap $508.65MP/E –Yield –

Immix Biopharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Immix Biopharma's price to book ratio was 2.7× on Nov 11, 2026, against 13.6× a year earlier. Over the last 5 years it ranged from 0.8× to 23.2×, with a median of 3.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.7×−20.5
2025Oct 31, 202523.2×+19.8
2024Dec 31, 20243.4×−3.4
2023Dec 29, 20236.9×+5.0
2022Dec 30, 20221.9×–

More Immix Biopharma figures

See a number that looks wrong?